Imagine a virus that hospitalizes thousands of people every winter, particularly vulnerable infants and the elderly. Now imagine a vaccine that could prevent it, but at a staggering cost. That's the dilemma Ireland faces with Respiratory Syncytial Virus (RSV).
The Health Information and Quality Authority (HIQA) has just released a draft report highlighting the substantial financial burden of implementing a national RSV vaccination program. While RSV is a common virus affecting the lungs and airways, it can lead to severe illness, especially in young children and older adults.
Here’s the catch: HIQA estimates that vaccinating all infants would cost the HSE an additional €50 to €60 million over five years. But here's where it gets controversial: extending this protection to adults aged 80 and over would add another €70 million to the bill.
Currently, the HSE is piloting RSV vaccination for specific infant groups, using newer immunisation products. However, adults remain unprotected. Dr. Máirín Ryan, HIQA’s Deputy CEO, emphasizes that the new RSV vaccines are expensive, and significant price reductions would be necessary to make any immunisation strategy cost-effective.
And this is the part most people miss: while infant immunisation offers protection for one season, older adults could be shielded for up to three RSV seasons. Yet, despite these benefits, the cost remains a major hurdle.
Interestingly, 22 European countries have already introduced RSV immunisation programs for infants, with eight extending coverage to older adults. Two years ago, Ireland’s National Immunisation Advisory Committee recommended RSV vaccination for those aged 75 and older, as well as certain groups aged 60 and older.
Is the cost of RSV vaccination justified, or should resources be allocated elsewhere? The public consultation on HIQA’s draft report is now open, inviting your thoughts on this critical issue. With over 7,000 RSV diagnoses in Ireland each winter, the stakes are high. What do you think? Should Ireland prioritize this costly but potentially life-saving measure, or is there a better way to protect its most vulnerable citizens? Let’s spark the debate!
